| Issue Date | Title | Author(s) |
| 2018-09-15 | Disruption of a 35 KB enhancer impairs CTCF binding and MLH1 expression in colorectal cells | Liu, Q; Thoms, JAI; Nunez, AC; Huang, Y; Knezevic, K; Packham, D; Poulos, RC; Williams, R; Beck, D; Hawkins, NJ; Ward, RL; Wong, JWH; Hesson, LB; Sloane, MA; Pimanda, JE |
| 2023-10-25 | Mitotic Dysregulation at Tumor Initiation Creates a Therapeutic Vulnerability to Combination Anti-Mitotic and Pro-Apoptotic Agents for MYCN-Driven Neuroblastoma. | Zhai, L; Balachandran, A; Larkin, R; Seneviratne, JA; Chung, SA; Lalwani, A; Tsubota, S; Beck, D; Kadomatsu, K; Beckers, A; Durink, K; De Preter, K; Speleman, F; Haber, M; Norris, MD; Swarbrick, A; Cheung, BB; Marshall, GM; Carter, DR |
| 2024-01 | MYCN and SNRPD3 cooperate to maintain a balance of alternative splicing events that drives neuroblastoma progression. | Salib, A; Jayatilleke, N; Seneviratne, JA; Mayoh, C; De Preter, K; Speleman, F; Cheung, BB; Carter, DR; Marshall, GM |
| 2024-07-11 | The transcriptional co-repressor Runx1t1 is essential for MYCN-driven neuroblastoma tumorigenesis. | Murray, JE; Valli, E; Milazzo, G; Mayoh, C; Gifford, AJ; Fletcher, JI; Xue, C; Jayatilleke, N; Salehzadeh, F; Gamble, LD; Rouaen, JRC; Carter, DR; Forgham, H; Sekyere, EO; Keating, J; Eden, G; Allan, S; Alfred, S; Kusuma, FK; Clark, A; Webber, H; Russell, AJ; de Weck, A; Kile, BT; Santulli, M; De Rosa, P; Fleuren, EDG; Gao, W; Wilkinson-White, L; Low, JKK; Mackay, JP; Marshall, GM; Hilton, DJ; Giorgi, FM; Koster, J; Perini, G; Haber, M; Norris, MD |
